News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
371,395 Results
Type
Article (15700)
Company Profile (118)
Press Release (355577)
Multimedia
Podcasts (42)
Webinars (9)
Section
Business (113932)
Career Advice (829)
Deals (18909)
Drug Delivery (41)
Drug Development (31771)
Employer Resources (61)
FDA (8968)
Job Trends (7847)
News (175890)
Policy (13398)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (1370)
Accelerated approval (3)
Adcomms (2)
Allergies (43)
Alliances (34943)
ALS (27)
Alzheimer's disease (533)
Antibody-drug conjugate (ADC) (73)
Approvals (8982)
Artificial intelligence (240)
Autoimmune disease (4)
Automation (13)
Bankruptcy (153)
Best Places to Work (6645)
BIOSECURE Act (8)
Biosimilars (13)
Biotechnology (88)
Bladder cancer (24)
Brain cancer (12)
Breast cancer (117)
Cancer (1024)
Cardiovascular disease (65)
Career advice (698)
Career pathing (14)
CAR-T (103)
Cell therapy (269)
Cervical cancer (10)
Clinical research (24929)
Collaboration (605)
Compensation (111)
Complete response letters (6)
COVID-19 (1195)
CRISPR (36)
C-suite (150)
Cystic fibrosis (47)
Data (979)
Decentralized trials (1)
Denatured (19)
Depression (16)
Diabetes (109)
Diagnostics (4936)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (13)
Drug discovery (77)
Drug pricing (36)
Drug shortages (6)
Duchenne muscular dystrophy (24)
Earnings (39384)
Editorial (9)
Employer branding (10)
Employer resources (53)
Events (52258)
Executive appointments (402)
FDA (9623)
Featured Employer (27)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (482)
Gene editing (84)
Generative AI (24)
Gene therapy (173)
GLP-1 (240)
Government (1456)
Grass and pollen (3)
Guidances (28)
Healthcare (10140)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (31)
Indications (13)
Infectious disease (1274)
Inflammatory bowel disease (62)
Inflation Reduction Act (6)
Influenza (32)
Intellectual property (61)
Interviews (167)
IPO (8181)
IRA (13)
Job creations (1483)
Job search strategy (592)
Kidney cancer (4)
Labor market (12)
Layoffs (128)
Leadership (6)
Legal (2978)
Liver cancer (34)
Lung cancer (127)
Lymphoma (63)
Machine learning (4)
Management (20)
Manufacturing (186)
MASH (16)
Medical device (11588)
Medtech (11593)
Mergers & acquisitions (11081)
Metabolic disorders (227)
Multiple sclerosis (30)
NASH (3)
Neurodegenerative disease (34)
Neuropsychiatric disorders (6)
Neuroscience (737)
NextGen: Class of 2025 (3666)
Non-profit (1672)
Northern California (1099)
Now hiring (9)
Obesity (101)
Opinion (99)
Ovarian cancer (39)
Pain (50)
Pancreatic cancer (41)
Parkinson's disease (68)
Partnered (12)
Patents (148)
Patient recruitment (56)
Peanut (28)
People (33112)
Pharmaceutical (18)
Pharmacy benefit managers (9)
Phase I (9135)
Phase II (11243)
Phase III (7352)
Pipeline (561)
Policy (57)
Postmarket research (539)
Preclinical (4124)
Press Release (66)
Prostate cancer (42)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (143)
Real estate (3389)
Recruiting (24)
Regulatory (9824)
Reports (19)
Research institute (1303)
Resumes & cover letters (123)
Rett syndrome (3)
RNA editing (2)
RSV (23)
Schizophrenia (17)
Series A (88)
Series B (52)
Service/supplier (7)
Sickle cell disease (18)
Southern California (1199)
Special edition (3)
Spinal muscular atrophy (59)
Sponsored (13)
Startups (2524)
State (2)
Stomach cancer (2)
Supply chain (27)
Tariffs (6)
The Weekly (22)
United States (11626)
Vaccines (340)
Venture capitalists (19)
Weight loss (45)
Women's health (17)
Worklife (7)
Date
Today (89)
Last 7 days (326)
Last 30 days (1287)
Last 365 days (17580)
2025 (5234)
2024 (19040)
2023 (22377)
2022 (31167)
2021 (32880)
2020 (31037)
2019 (26430)
2018 (19931)
2017 (19188)
2016 (18064)
2015 (20883)
2014 (15406)
2013 (12959)
2012 (14046)
2011 (14336)
2010 (13050)
Location
Africa (371)
Alabama (40)
Alaska (6)
Arizona (123)
Arkansas (10)
Asia (24289)
Australia (4279)
California (2915)
Canada (1059)
China (242)
Colorado (168)
Connecticut (130)
Delaware (45)
Europe (50083)
Florida (477)
Georgia (136)
Idaho (33)
Illinois (288)
India (14)
Indiana (163)
Iowa (5)
Japan (113)
Kansas (82)
Kentucky (6)
Louisiana (7)
Maine (21)
Maryland (461)
Massachusetts (2033)
Michigan (185)
Minnesota (249)
Mississippi (2)
Missouri (61)
Montana (24)
Nebraska (16)
Nevada (22)
New Hampshire (66)
New Jersey (909)
New Mexico (16)
New York (864)
North Carolina (534)
North Dakota (7)
Northern California (1099)
Ohio (104)
Oklahoma (11)
Oregon (20)
Pennsylvania (593)
Puerto Rico (9)
Rhode Island (26)
South America (573)
South Carolina (20)
South Dakota (1)
Southern California (1199)
Tennessee (62)
Texas (468)
Utah (118)
Virginia (58)
Washington D.C. (16)
Washington State (340)
West Virginia (3)
Wisconsin (36)
371,395 Results for "innerscope hearing technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
InnerScope Hearing Technologies (OTC:INND) Launches its iHEAR Matrix OTC Hearing Aids in 4218 Walmart Stores
InnerScope Hearing Technologies Inc. announced it is launching the iHEAR Matrix Rechargeable OTC Hearing Aids with Walmart as part of Walmart’s OTC hearing aid display fixture located in 4,218 Walmart stores nationwide.
November 16, 2023
·
7 min read
Press Releases
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
Seek to clarify that certain hearing implants are prosthetics and therefore not subject to the hearing aid coverage exclusion, allowing for potential Medicare coverage
March 17, 2025
·
7 min read
Biotech Beach
InnerScope Hearing Technologies (OTC: INND) Launches Hearing
InnerScope Hearing Technologies Inc. announced the launch of its HearingAssist brand FDA-Registered Over-the-Counter Rechargeable Hearing Aids including its EZHear Neckband Amplifier and other assorted HearingAssist branded hearing and hearing related supplies on Walgreens.com.
April 5, 2023
·
8 min read
BioMidwest
InnerScope Hearing Technologies (OTC: INND) Retains SmallCapVoice.com to Amplify Investor Relations and Digital Marketing Initiatives
InnerScope Hearing Technologies Inc. announced has retained SmallCapVoice.com, a seasoned, yet dynamic firm with a focus on compliant investor relations, digital marketing, and community management services tailored for publicly traded companies.
September 7, 2023
·
7 min read
Biotech Beach
InnerScope Hearing Technologies (OTC: INND) Subsidiary HearingAssist Celebrates World Hearing Day By Offering OTC Hearing Aids in 1500+ Walmart Vision Centers
InnerScope Hearing Technologies Inc., an emerging and disruptive leader in the Over-the-Counter Hearing Aid space announced together with its subsidiary, HearingAssist Inc.
March 2, 2023
·
8 min read
Business
InnerScope Hearing Technologies (OTC: INND) Announces Profitable Year-End 2022 Financial Results
InnerScope Hearing Technologies Inc., an emerging and disruptive leader in the Over-the-Counter hearing aid space, announced its unaudited financial results for the full year ended December 31, 2022.
April 3, 2023
·
10 min read
Biotech Bay
InnerScope Hearing Technologies Announces its Hearing Assist Brand of OTC Hearing Aids on RiteAid.com
InnerScope Hearing Technologies Inc. announced today that its subsidiary HearingAssist Americas’s #1 Affordable OTC Hearing Brand has launched a complete line of FDA-Registered Over-the-Counter (“OTC”) Rechargeable Hearing Aids (“HearingAssist OTC Hearing Aids”) and assorted hearing and hearing related supplies on RiteAid.com.
November 22, 2022
·
7 min read
Government
Anxious Industry Awaits Makary’s Hearing Amid Disruptions, Layoffs at FDA
The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump’s NIH pick, Jay Bhattacharya, was grilled by the legislative body on Wednesday.
March 6, 2025
·
2 min read
·
Tristan Manalac
BioMidwest
InnerScope Hearing Technologies (OTC: INND) Announces its HearingAssist Brand of FDA-Registered OTC Rechargeable Hearing Aids on CVS.com
InnerScope Hearing Technologies Inc., an emerging and disruptive leader in the Over-the-Counter Hearing Aid space announced its subsidiary HearingAssist, America’s #1 Affordable OTC Hearing Aid Brand had launched its FDA-Registered Over-the-Counter Rechargeable Hearing Aids on CVS.com.
December 22, 2022
·
7 min read
Business
InnerScope Hearing Technologies (OTC: INND) Partners With NUHEARA For Licensing FDA-Cleared Self-Fitting OTC Hearing Aid Technology
InnerScope Hearing Technologies Inc. (OTC: INND) (“InnerScope”), an emerging and disruptive leader in the Over-the-Counter (OTC) Hearing Aid space today announced it had signed a Memorandum of Understanding (“MOU”) with NUHEARA Limited (ASX: NUH) (“NUHEARA”), a Medical device and consumer electronics manufacturer listed on the Australian Stock Market.
December 20, 2022
·
10 min read
1 of 37,140
Next
